Data Horizon Co., Ltd. (3628) AI Stock Analysis

• Market Cap: ¥7.00B
• Dividend Yield: N/A
• Average Volume (3M): 17.62K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.60
• Revenue Growth: -2.60%
• EPS Growth: -103.03%
• Country: JP
• Employees: 374
• Sector: Healthcare
• Sector Strength: 50
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -4.39
• Shares Outstanding: 12,711,780
• 10 Day Avg. Volume: 6,160
• 30 Day Avg. Volume: 17,620
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥528.00
• Price Target Upside: -4.17% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: ¥528.00 ▼(-4.17% Downside)

Data Horizon Co., Ltd. receives a low overall stock score due primarily to its challenging financial performance, characterized by declining revenues and negative profitability. Technical analysis offers a slightly more neutral outlook, but the valuation remains poor with a negative P/E ratio. The lack of earnings call data and corporate events means these factors do not influence the score.

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company Description

Data Horizon Co., Ltd. (3628) is a company specializing in healthcare data management and analytics. It operates in the healthcare information technology sector, providing services that optimize the management and utilization of medical records and data. Its core products and services include electronic health record (EHR) systems, data analytics solutions, and healthcare IT consulting services, aimed at enhancing the efficiency and efficacy of healthcare providers.

How the Company Makes Money

Data Horizon Co., Ltd. generates revenue primarily through the sale and licensing of its electronic health record (EHR) systems and healthcare data analytics solutions. The company earns income from subscription fees for its software services and consulting fees for providing IT solutions tailored to healthcare institutions. Its key revenue streams include direct sales to hospitals, clinics, and other healthcare providers, as well as long-term contracts for software maintenance and upgrades. Significant partnerships with healthcare organizations and government bodies also contribute to its financial performance, enabling the company to expand its reach and service offerings.

Data Horizon Co., Ltd. Financial Statement Overview

Summary

Data Horizon Co., Ltd. faces significant financial challenges, including declining revenues, negative profitability margins, and increasing leverage. The weak cash flow generation further exacerbates these issues, highlighting liquidity risks. The company needs strategic measures to enhance revenue growth and improve operational efficiency to stabilize its financial position.

Income Statement

The company exhibits a significant decline in revenue and profitability, with negative EBIT and net income margins for both TTM and annual data. Revenue growth has been inconsistent, and recent periods show a contraction in sales. The gross profit margin remains relatively high but is undermined by substantial operating losses.

Balance Sheet

The balance sheet shows high leverage with a rising debt-to-equity ratio, indicating increased financial risk. Stockholders' equity has been declining, further affecting the equity ratio negatively. While total assets have grown, the increase in liabilities poses a challenge to financial stability.

Cash Flow

Cash flow statements reveal negative free cash flow in recent periods, with operating cash flow unable to cover capital expenditures. The company's cash generation ability is weak, with no positive free cash flow growth observed. This raises concerns about liquidity and the ability to sustain operations without external financing.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	5.01B	4.41B	2.99B	3.33B	2.78B
Gross Profit	1.49B	1.42B	1.26B	1.78B	1.45B
EBITDA	-148.66M	-222.73M	-246.87M	478.03M	395.04M
Net Income	-807.18M	-664.86M	-410.80M	283.92M	201.76M
Balance Sheet
Total Assets	6.66B	6.39B	2.26B	2.28B	1.99B
Cash, Cash Equivalents and Short-Term Investments	1.42B	1.08B	379.98M	1.06B	1.12B
Total Debt	2.46B	1.47B	400.00M	2.66M	16.02M
Total Liabilities	3.44B	2.36B	977.21M	709.94M	687.49M
Stockholders Equity	3.19B	3.97B	1.26B	1.54B	1.28B
Cash Flow
Free Cash Flow	-678.92M	-923.59M	-1.04B	68.16M	402.95M
Operating Cash Flow	120.13M	-198.37M	-442.98M	395.94M	532.86M
Investing Cash Flow	-789.14M	-3.51B	-572.80M	-391.51M	-80.47M
Financing Cash Flow	1.02B	4.41B	331.20M	-56.21M	-41.58M

Data Horizon Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 551.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Neutral. The current price of 551 is below the 20-day moving average (MA) of 565.80, below the 50-day MA of 561.04, and above the 200-day MA of 482.42, indicating a neutral trend. The MACD of -2.98 indicates Positive momentum. The RSI at 45.97 is Neutral, neither overbought nor oversold. The STOCH value of 25.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	85 Outperform	¥7.94B	12.25		8.93%	26.12%	38.78%
4172	76 Outperform	¥5.05B	12.26		4.46%	13.40%	21.76%
6095	67 Neutral	¥15.32B	10.15		0.64%	-17.86%	133.08%
Sector *	54 Neutral	€4.17B	12.59	-36.14%	2.46%	15.95%	-24.06%
3628	45 Neutral	¥7.00B	―		―	-2.60%	-103.03%
4263	45 Neutral	¥14.10B	―		―	35.15%	16.85%
3902	43 Neutral	¥21.37B	4,465.71		1.14%	-0.58%	-260.22%